Read + Share
de Castro G Jr, Rizvi NA, Schmid P, Syrigos K, et al. NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients
With Metastatic NSCLC. J Thorac Oncol 2023;18:106-119.
PMID: 36240972
|
 |
|
de Castro G Jr, Rizvi NA, Schmid P, Syrigos K, et al. NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients
With Metastatic NSCLC. J Thorac Oncol 2023;18:106-119.
PMID: 36240972
|
|
|
|